*By Brian Henry* Fans of the tearjerker "A Walk to Remember" might not recognize star Shane West. In stark contrast to his role as Landon ー reformed bad boy and star-crossed lover to Mandy Moore's Jamie ー the actor is making his debut on Fox's "Gotham" as one of DC Comics' most notorious villains: Bane. According to West, the series creators saved one of the best nemeses for last. "It was the final season, they saved their one big, bad villain that they hadn't done in five years for the end," he told Cheddar. For West, a rabid fan of comics, the role is the culmination of a "random dream come true." "They called me about it. I had never played a hero or a villain from a comic book and to have this be my first one. And to work in New York for a few months ー I had never worked in New York ー it was a no-brainer." Even though his breakthrough film, "A Walk to Remember," is 17 years in the past, West said the story endures. "It was a very touching story and with a lot of those types of stories and movies its based on chemistry," he said. West said he couldn't have anticipated the film would resonate so deeply with viewers ー but he gives his co-star, then a newcomer to the business, plenty of the credit. "Mandy was wonderful and kind of new into the acting world. She'd been around as a pop star at the time. I was on a TV show and had done a couple films before that. We were both basically new." "People have continued to watch it for 17 years," he added. Almost two decades later, West is more than ready to embody a new kind of character. "Gotham" airs Thursdays on Fox. For full interview [click here](https://cheddar.com/videos/shane-west-talks-tackling-the-role-of-iconic-batman-villain).

Share:
More In Culture
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Bitcoin Price Tumbles First Week of 2022
Ben Armstrong, founder of Bitboy Crypto, joins Cheddar News to discuss Bitcoin's downward trend and what's next for crypto after protests in Kazakhstan cause crypto miners to shut down.
Pearson CEO Says Flexibility Is Key to Maximize Remote Instruction for Students
The highly transmissible omicron variant of COVID-19 has forced school districts nationwide to return to virtual instruction, but there remain concerns about the quality of education students are receiving online. Andy Bird, CEO of Pearson, an education publisher and assessment service provider, joined Cheddar's "Opening Bell" to talk about steps educators and parents can take to make the remote learning experience an easier one, noting that one of the biggest advantages teachers can have is flexibility. "You cannot take a rigid timetable that works in the analog world and replicate that in the digital world. You need to have flexibility. Asynchronous learning, I think, is a very important part," he told Cheddar.
2022 Goals for Business Owners
Julie Elledge, Founder and CEO of Mentor Agility, joins ChedHER to discuss what goals business owners should set in the new year, and what tools are out there for emerging entrepreneurs.
Load More